Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Demanet

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Leukemia|November 30, 2007
NK cell receptors and their ligands in leukemiaS Verheyden, C Demanet
The Quarterly Journal of Medicine|October 1, 1976
Clinical, biological and pathogenic features of the syndrome of inappropriate secretion of antidiuretic hormone. A review of 26 cases with marked hyponatraemiaA De Troyer, J C Demanet
Biogerontology|May 13, 2004
Inflammatory status as an important determinant of heat shock protein 70 serum concentrations during agingR Njemini, C Demanet, T Mets
Leukemia|October 8, 2004
Identification of natural killer cell receptor phenotypes associated with leukemiaS Verheyden, M Bernier, C Demanet
Psychiatry Research|April 9, 1999
Immune dysfunction associated with chronic professional stress in nursesV De Gucht, B Fischler, C Demanet
Scandinavian Journal of Immunology|November 26, 2003
Elevated serum heat-shock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assayR Njemini, M Lambert, C Demanet, et al.
Leukemia|June 24, 2005
A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantationS Verheyden, R Schots, W Duquet, et al.
Experimental Gerontology|March 1, 2006
The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytesR Njemini, M Lambert, C Demanet, et al.
Blood|May 15, 1996
Bispecific antibody-mediated immunotherapy of the BCL1 lymphoma: increased efficacy with multiple injections and CD28-induced costimulationC Demanet, J Brissinck, J De Jonge, et al.
Journal of Hematotherapy|October 1, 1995
In vivo studies using bispecific antibodies (anti-CD3 x anti-idiotype) and CD28-induced costimulation in the BCL1 lymphomaC Demanet, J Brissinck, J De Jonge, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Leukemia|November 30, 2007
NK cell receptors and their ligands in leukemiaS Verheyden, C Demanet
The Quarterly Journal of Medicine|October 1, 1976
Clinical, biological and pathogenic features of the syndrome of inappropriate secretion of antidiuretic hormone. A review of 26 cases with marked hyponatraemiaA De Troyer, J C Demanet
Biogerontology|May 13, 2004
Inflammatory status as an important determinant of heat shock protein 70 serum concentrations during agingR Njemini, C Demanet, T Mets
Leukemia|October 8, 2004
Identification of natural killer cell receptor phenotypes associated with leukemiaS Verheyden, M Bernier, C Demanet
Psychiatry Research|April 9, 1999
Immune dysfunction associated with chronic professional stress in nursesV De Gucht, B Fischler, C Demanet
Scandinavian Journal of Immunology|November 26, 2003
Elevated serum heat-shock protein 70 levels in patients with acute infection: use of an optimized enzyme-linked immunosorbent assayR Njemini, M Lambert, C Demanet, et al.
Leukemia|June 24, 2005
A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantationS Verheyden, R Schots, W Duquet, et al.
Experimental Gerontology|March 1, 2006
The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytesR Njemini, M Lambert, C Demanet, et al.
Blood|May 15, 1996
Bispecific antibody-mediated immunotherapy of the BCL1 lymphoma: increased efficacy with multiple injections and CD28-induced costimulationC Demanet, J Brissinck, J De Jonge, et al.
Journal of Hematotherapy|October 1, 1995
In vivo studies using bispecific antibodies (anti-CD3 x anti-idiotype) and CD28-induced costimulation in the BCL1 lymphomaC Demanet, J Brissinck, J De Jonge, et al.
Pageof 4